Occudo Quantitative Strategies’s Atlanta Braves Holdings Series B BATRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$445K Buy
8,576
+1,255
+17% +$61.6K 0.02% 522
2026
Q1
$362K Buy
7,321
+1,282
+21% +$53.3K 0.02% 554
2025
Q4
$238K Sell
6,039
-8,098
-57% -$320K 0.02% 554
2025
Q3
$588K Buy
14,137
+6,313
+81% +$279K 0.07% 366
2025
Q2
$366K Sell
7,824
-133
-2% -$5.44K 0.04% 417
2025
Q1
$319K Buy
+7,957
New +$310K 0.04% 461

Other funds holding BATRK

Occudo Quantitative Strategies's BATRK Position: Q2 2026 in Review

Occudo Quantitative Strategies increased its Atlanta Braves Holdings Series B (BATRK) stake by 17% in Q2 2026, buying an estimated $61.6K and bringing the position to 8,576 shares worth $445K. The position accounts for 0.02% of the portfolio, ranked #522.

Occudo Quantitative Strategies first reported a position in BATRK in Q1 2025 and has held it in 6 quarters since. The position peaked at $588K in Q3 2025. 325 funds tracked by Wall St. Rank hold BATRK as of Q2 2026.

  • Occudo Quantitative Strategies held 8,576 shares of Atlanta Braves Holdings Series B worth $445K as of Q2 2026.
  • Occudo Quantitative Strategies bought 1,255 Atlanta Braves Holdings Series B shares in Q2 2026, an estimated $61.6K.
  • Atlanta Braves Holdings Series B made up 0.02% of Occudo Quantitative Strategies's portfolio in Q2 2026, its #522 holding.
  • Occudo Quantitative Strategies first reported a position in Atlanta Braves Holdings Series B in Q1 2025 and has held it in 6 quarters since.
  • Occudo Quantitative Strategies's Atlanta Braves Holdings Series B position peaked at $588K in Q3 2025.
  • 325 funds tracked by Wall St. Rank held Atlanta Braves Holdings Series B as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.